Kaposi's sarcoma: Advances and perspectives

Journal of the American Academy of Dermatology

Volumn 34, Issue 5 I, 1996, Pages 804-814

  Schwartz, Robert A ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 CHLORO 2,4 DINITROBENZENE; ALPHA INTERFERON; ANGIOGENESIS INHIBITOR; ANTHRACYCLINE; ANTINEOPLASTIC AGENT; BASIC FIBROBLAST GROWTH FACTOR; BLEOMYCIN; CD8 ANTIGEN; CYCLOSPORIN; CYTOKINE; DAUNORUBICIN; DOXORUBICIN; FUMAGILLOL; IMMUNOTOXIN; INTERLEUKIN 4; INTERLEUKIN 6 ANTIBODY; LIPOSOME; ONCOSTATIN M; PACLITAXEL; PENTOXIFYLLINE; PIPERANOMETOZINE; RETINOID; SCATTER FACTOR; TRANSACTIVATOR PROTEIN; VINBLASTINE; VINCA ALKALOID;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CANCER STAGING; CLINICAL FEATURE; CLINICAL TRIAL; CONTINUOUS INFUSION; CRYOSURGERY; DIFFERENTIAL DIAGNOSIS; HERPES VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HYPERTHERMIC THERAPY; INTRALESIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; KAPOSI SARCOMA; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; REVIEW; TUMOR GROWTH;

EID: 0029918077     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0190-9622(96)90018-3     Document Type: Review

References (188)

1. Northfelt DW. AIDS-related Kaposi's sarcoma: still a problem, still an opportunity. J Clin Oncol 1994;12:1109-10.
2. Hymes K, Cheung T, Green JB. Kaposi's sarcoma in homosexual men. Lancet 1981;2:598-600.
3. Borkovic SP, Schwartz RA. Kaposi's sarcoma presenting in the homosexual man - a new and striking phenomenon. Ariz Med 1981;38:902-4.
4. Gottlieb GJ, Ragaz A, Vogel JV, et al. A preliminary communication on extensively disseminated Kaposi's sarcoma in young homosexual men. Am J Dermatopathol 1981;3:111-4.
5. Friedman-Kien AE. Disseminated Kaposi' s sarcoma syndrome in young homosexual men. J AM ACAD DERMATOL 1981;5:468-71.
6. Kaposi's sarcoma and Pneumocystis pneumonia among homosexual men - New York and California. MMWR 1981;30:305-8.
7. Kaposi M. Idiopathisches multiples Pigmentsarkom der Haut. Arch f Dermatol u Syphil (Prague) 1872;3:265-73.
8. Richter F, Hill GJ, Schwartz RA. Kaposi's sarcoma: Professor Kaposi's original concepts. J Cancer Educ 1995; 10:113-6.
9. Breimer L. Original description of Kaposi's sarcoma. BMJ 1994;308:1303-4.
10. Root-Bernstein RS. AIDS and Kaposi sarcoma pre-1979 [Letter]. Lancet 1990;335:969.
11. Witte MH, Stunte M, Witte CL. Kaposi's sarcoma: a lymphologic perspective. Int J Dermatol 1989;28:561-70.
12. Laor Y, Schwartze RA. Epidemiologic aspects of American Kaposi's sarcoma. J Surg Oncol 1979;12:299-303.
13. Schwartz RA, Kardashian JF, McNutt NS, et al. Cutaneous angiosarcoma resembling anaplastic Kaposi's sarcoma in a homosexual man. Cancer 1983;51:721-6.
14. Schwartz RA, Volpe JA, Lambert MW, et al. Kaposi's sarcoma. Semin Dermatol 1984;3:303-15.
15. Kaposi M. Pathology and treatment of diseases of the skin for practitioners and students. Translation of the last German edition under the supervision of James C. Johnston, MD. New York: William Wood, 1895:601-3.
16. Schwartz RA, Burgess GH, Hoshaw RA. Patch stage Kaposi's sarcoma. J AM ACAD DERMATOL 1980;2:509-12.
17. Schwartz RA, Brenden LD, Breeden JH, et al. Indolent lymphadenopathic Kaposi's sarcoma. J Surg Oncol 1987; 34:243-7.
18. Snyder RA, Schwartz RA. Telangiectatic Kaposi's sarcoma: occurrence in a patient with thymoma and myasthenia gravis receiving long-term immunosuppressive therapy. Arch Dermatol 1982;118:1020-1.
19. Schwartz RA, Spicer MS, Thomas I, et al. Ecchymotic Kaposi's sarcoma. Cutis 1995;56:104-6.
20. Frans E, Blockmans D, Peetermans W, et al. Kaposi's sarcoma presenting as generalized lymphedema. Acta Clin Belg 1994;49:19-22.
21. Schwartz RA, Spicer MS, Janniger CK, et al. Keloidal Kaposi's sarcoma: report of three cases. Dermatology (Basel) 1994;189:271-4.
22. Mugoni MG, Cottoni F, Chiarolini F. Lymphedema and Kaposi's sarcoma: How and why? J Geriatr Dermatol 1994;2:183-5.
23. Sakurada S, Mori KM, Salahuddin SZ, et al. Vascular endothelial growth factor produced by cultured AIDS-associated Kaposi's sarcoma spindle cells. In: Abstracts: Tenth International Conference on AIDS. International Conference on STD, The global challenge of AIDS: together for the future. Yokohama, Japan Aug 7-12, 1994. No. PAO131 1994:128.
24. Wabinga HR, Parkin DM, Wabwire-Mangen F, et al. Cancer in Kampala, Uganda, in 1989-1991: changes in incidence in the era of AIDS. Int J Cancer 1993;54:26-36.
25. Thijs A. L'Angiosarcomatose de Kaposi au Congo belge et au Ruanda-Urundi. Ann Soc Belge Med Trop 1957; 37:295-307.
26. Athale UH, Patil PS, Chintu C, et al. Influence of HIV epidemic on the incidence of Kaposi's sarcoma in Zambian children. J AIDS Human Retrovirol 1995;8:96-100.
27. Geddes M, Franceschi S, Barchielli A, et al. Kaposi's sarcoma in Italy before and after the AIDS epidemic. Br J Cancer 1994;69:333-6.
28. Trattner A, Hodak E, David M, et al. The appearance of Kaposi sarcoma during corticosteroid therapy. Cancer 1993;72:1779-83.
29. Hoshaw RA, Schwartz RA. Kaposi's sarcoma after immunosuppressive therapy with prednisone. Arch Dermatol 1980;116:1280-2.
30. Al-Sulaiman MH, Mousa DH, Rassoul Z, et al. Transplant-related Kaposi sarcoma in children. Nephrol Dial Transplant 1994;9:443-5.
31. Qunibi WY, Barri Y, Almeshari K, et al. Kaposi's sarcoma in renal transplantation recipients: a report on 26 cases from a single institution. Transplant Proc 1993; 25:1402-5.
32. Zahger D, Lotan C, Admon D, et al. Very early appearance of Kaposi's sarcoma after cardiac transplantation in Sephardic Jews. Am Heart J 1993;126:999-1000.
33. Margolius L, Stein M, Spencer D, et al. Kaposi' s sarcoma in renal transplant recipients: experience at Johannesburg Hospital, 1966-1989. S Afr Med J 1994;84:16-7.
34. Montagnino G, Bencini PL, Tarantino A, et al. Clinical features and course of Kaposi's sarcoma in kidney transplant patients: report of 13 cases. Am J Nephrol 1994; 14:121-6.
35. Carmeli Y, Mevorach D, Kaminski N, et al. Regression of Kaposi's sarcoma after intravenous immunoglobulin treatment for polymyositis. Cancer 1994;73:2859-61.
36. Stein ME, Spencer D, Ruff P, et al. Endemic African Kaposi's sarcoma: clinical and therapeutic implications. Oncology 1994;51:63-9.
37. Montaner JSG, Le T, Hogg R, et al. The changing spectrum of AIDS index diseases in Canada. AIDS 1994; 8:693-6.
38. Biggar RJ, Curtis RE, Cote TR, et al. Risk of other cancers following Kaposi's sarcoma: relation to acquired immunodeficiency syndrome. Am J Epidemiol 1994; 139: 362-8.
39. Miles SA, Wang H, Elashoff R, et al. Improved survival for patients with AIDS-related Kaposi's sarcoma. J Clin Oncol 1994;12:1910-6.
40. Armenian HK, Hoover DR, Rubb S, et al. Composite risk score for Kaposi's sarcoma based on a case-control and longitudinal study in the multicenter AIDS cohort study (MACS) population. Am J Epidemiol 1993;138: 256-65.
41. Gross DJ, Safai B. Kaposi's sarcoma/AIDS cofactors. Int J Dermatol 1989;28:571-3.
42. Whitworth JM, Janniger CK, Oleske JM, et al. Cutaneous manifestations of childhood acquired immunodeficiency syndrome and human immunodeficiency virus infection. Cutis 1995;55:62-72.
43. Smith E, Hasseltvedt V, Böttiger M. The AIDS epidemic among Scandinavian women: 1980-1990. AIDS 1994;8: 689-92.
44. Hoover DR, Black C, Jacobson LP, et al. Epidemiologic analysis of Kaposi's sarcoma as an early and later AIDS outcome in homosexual men. Am J Epidemiol 1993; 138: 266-78.
45. Tappero JW, Conant MA, Wolfe SF, et al. Kaposi's sarcoma. J AM ACAD DERMATOL 1993;28:371-95.
46. Schwartz RA. Kaposi's sarcoma. In: Skin cancer recognition and management. New York: Springer-Verlag 1988;80-98.
47. Ruszczak Z, Schwartz RA. Vascular endothelium in the regulation of immune response. J Med (In press.)
48. Marmor M, Winchester R, Zeleniuch-Jacquotta A, et al. Evidence for an effect of human leukocyte antigens on susceptibility to Kaposi's sarcoma related to charge and peptide-binding properties of class I molecules. AIDS 1995;9:1194-5.
49. Beral V, Bull D, Darby S, et al. Risk of Kaposi' s sarcoma and sexual practices associated with faecal contact in homosexuals or bisexual men with AIDS. Lancet 1992; 339:632-5.
50. Papadopulos-Eleopulos E, Turner VF, Papadimitriou JM. Kaposi's sarcoma and HIV. Med Hypotheses 1992;39: 22-9.
51. Schechter MT, Marion SA, Elmslie KD, et al. Geographic and birth cohort associations of Kaposi's sarcoma among homosexual men in Canada. Am J Epidemiol 1991; 134:485-8.
52. Beral V, Peterman TA, Berkelman RL, et al. Kaposi's sarcoma among persons with AIDS: A sexually transmitted disease? Lancet 1990;335:123-8.
53. Tirelli U, Franceschi S, Carbone A. Malignant tumours in patients with HIV infection. Br Med J 1994;308:1148-53.
54. Borkovic SP, Schwartz RA. Kaposi's sarcoma. Am Fam Physician 1982;26(4):133-7.
55. Martin RW III, Hood AF, Farmer ER. Kaposi's sarcoma. Medicine 1993;72:245-61.
56. Roth WK, Brandstetter H, Stürzl M. Cellular and molecular features of HIV-associated Kaposi's sarcoma. AIDS 1992;6:895-913.
57. Schwartz RA. Sarcoma de Kaposi. JANO Medicina y Humanidades 1986;30:2511-7.
58. Rappersberger K, Tschachler E, Zonzits E, et al. Endemic Kaposi' s sarcoma in human immunodeficiency virus type 1-seronegative persons: demonstration of retrovirus-like particles in cutaneous lesions. J Invest Dermatol 1990; 95:371-81.
59. Lassoued K, Clauvel J-P, Fegueux S, et al. AIDS-associated Kaposi's sarcoma in female patients. AIDS 1991; 5:877-80.
60. Krigel RL, Friedman-Kien A. Epidemic Kaposi's sarcoma. Semin Oncol 1990;17:350-60.
61. O'Connell KM. Kaposi's sarcoma in lymph nodes: histological study of lesions from 16 cases in Malawi. J Clin Pathol 1977;30:696-703.
62. Slavin G, Cameron HMcD, Forbes C, et al. Kaposi's sarcoma in East African children: a report of 51 cases. J Pathol 1970;100:187-99.
63. Welch K, Finkbeiner W, Alpers CE, et al. Autopsy findings in the acquired immune deficiency syndrome. JAMA 1984;252:1152-9.
64. Friedman-Kien AE, Saltzman BR. Clinical manifestations of classical, endemic African, and epidemic AIDS-associated Kaposi's sarcoma. J AM ACAD DERMATOL 1990;22:1237-50.
65. Saltzman BR, Friedman-Kien AE, Huang YQ, et al. Epidemic Kaposi's sarcoma (EKS) in HIV-infected (HIV-neg) homosexual (HS) men: clinical course and analysis for known human retroviral genomic sequences by PCR. In: Eighth International Conference on AIDS/Third STD World Congress, Amsterdam, the Netherlands July 19-24, 1992, Amsterdam: CONGREX Holland BV, 1992.
66. Craighead J, Moore A, Grossman H, et al. Pathogenetic role of HIV infection in Kaposi's sarcoma of equatorial East Africa. Arch Pathol Lab Med 1988;112:259-65.
67. Chow JWM, Lucas SB. Endemic and atypical Kaposi's sarcoma in Africa - histopathological aspects. Clin Exp Dermatol 1990;15:253-9.
68. Tirelli U, Vaccher E, Lazzarin A, et al. Kaposi's sarcoma in Italy, a country with intravenous drug users as the main group affected by HIV infection. Antibiot Chemother 1991;43:115-23.
69. Fukunaga M, Silverberg SG. Kaposi' s sarcoma in patients with acquired immune deficiency syndrome: a flow cytometric DNA analysis of 26 lesions in 21 patients. Cancer 1990;66:758-64.
70. Volberding PA. Kaposi's sarcoma and the acquired immunodeficiency syndrome. Med Clin North Am 1986; 70:665-75.
71. Sengupta SK, Edwards K, Blair A, et al. Childhood Kaposi's sarcoma in Papua, New Guinea. Aust Paediatr J 1986;22:301-4.
72. Elford J, McDonald A, Kaldor J, et al. Kaposi's sarcoma as a sexually transmissible infection: an analysis of Australian AIDS surveillance data. AIDS 1993;7:1667-71.
73. Stein M, Spencer D, Kuten A, et al. AIDS-related Kaposi's sarcoma: a review. Isr J Med Sci 1994;30:298-305.
74. Bowden FJ, McPhee DA, Deacon NJ, et al. Antibodies to gp41 and nef in otherwise HIV-negative homosexual man with Kaposi's sarcoma. Lancet 1991;337:1313-4.
75. Piette WW. The incidence of second malignancies in subsets of Kaposi's sarcoma. J AM ACAD DERMATOL 1987;16:855-61.
76. Reynolds P, Saunders LD, Layefsky ME, et al. The spectrum of acquired immunodeficiency (AIDS)-associated malignancies in San Francisco, 1980-1987. Am J Epidemiol 1993;137:19-30.
77. Weiss SH, Biggar RJ. The epidemiology of human retrovirus-associated illnesses. Mt Sinai J Med 1986;53:579-91.
78. Owor R. Multiple primary malignant tumours in Ugandan Africans. East Afr Med J 1980;57:692-5.
79. Krigel RL, Laubenstein LJ, Muggia FM. Kaposi's sarcoma: a new staging classification. Cancer Treat Rep 1983;67:531-4.
80. Volberding PA. Moving towards a uniform staging for human immunodeficiency virus-associated Kaposi's sarcoma. J Clin Oncol 1989;7:1184-5.
81. Chuck S, Grant RM, Katongole-Mbidde E, et al. Frequent presence of a novel herpes virus genome in lesions of human immunodeficiency virus-negative Kaposi's sarcoma.
82. Gallant JE, Moore RD, Richman DD, et al. Risk factors for Kaposi's sarcoma in patients with advanced human immunodeficiency virus disease treated with zidovudine. Arch Intern Med 1994;154:566-72.
83. Wang RY-H, Shih JW-K, Weiss SH, et al. Mycoplasma penetrans infection in male homosexuals with AIDS: high seroprevalence and association with Kaposi's sarcoma. Clin Infect Dis 1993;17:724-9.
84. Lo S-C, Lange M, Wang R, et al. Development of Kaposi's sarcoma is associated with serologic evidence of Mycoplasma penetrans infection:retrospective analysis of a prospective cohort study of homosexual men. In: The First National Conference on Human Retroviruses and related infections. Program and Abstracts cosponsored by National Foundation for Infectious Diseases and the American Society for Microbiology in collaboration with National Institutes of Health and Centers for Disease Control, Dec 12-16, 1993, Washington, DC. [Abstract] Washington, DC: National Institutes of Health, 1993:145.
85. Zucker-Franklin D, Huang YQ, Grusky GE, et al. Kaposi's sarcoma in a human immunodeficiency virus-negative patient with asymptomatic human T lymphotropic virus type I infection. J Infect Dis 1993;167:987-9.
86. Stoica G. Sarcoma viruses containing the mos oncogene induce lesion resembling Kaposi's sarcoma. In Vivo 1994;8:43-7.
87. Heredia A, Muller J, Soriano V, et al. Absence of evidence of retroviral infection in idiopathic CD4+ T-lymphocytopenia syndrome. AIDS 1994;8:267-8.
88. Ziegler JL. Endemic Kaposi's sarcoma in Africa and local volcanic sous. Lancet 1993;342:1348-51.
89. Giraldo G, Beth E, Haguenau F. Herpes-type virus particles in tissue culture of Kaposi's sarcoma from different geographic regions. J Natl Cancer Inst 1972;49:1495-507.
90. Giraldo G, Beth E, Huang E-S. Kaposi's sarcoma and its relationship to cytomegalovirus (CMV). III. CMV DNA and CMV early antigens in Kaposi's sarcoma. Int J Cancer 1980;26:23-9.
91. Schwartz RA, Stewart-Treves syndrome. In: Demis DJ, ed. Clinical dermatology. 16th ed. Philadelphia: JB Lippincott, 1989 (Unit 7-77): 1-6.
92. Witte MH, Witte CL, Way DL. Medical ignorance, AIDS-Kaposi's sarcoma complex, and the lymphatic system. West J Med 1990;153:17-23.
93. Vogel J, Hinrichs SH, Reynolds RK, et al. The HIV tat gene induces dermal lesions resembling Kaposi's sarcoma in transgenic mice. Nature 1988;335:606-11.
94. + T cells. Science 1988;242:426-33.
95. Nair BC, DeVico AL, Nakamura S, et al. Identification of a major growth factor for AIDS-Kaposi's sarcoma cells as oncostatin M. Science 1992;255:1430-2.
96. Miles SA, Martínez-Maza O, Rezai A, et al. Oncostatin M as a potent mitogen for AIDS-Kaposi's sarcoma-derived cells. Science 1992;255:1432-4.
97. Cai J, Gill PS, Masood R, et al. Oncostatin-M is an autocrine growth factor in Kaposi's sarcoma. Am J Pathol 1994;145:74-9.
98. Hamilton AS, Radka SF, Bernstein L, et al. Relationship of serum levels of oncostatin M to AIDS-related and classic Kaposi's sarcoma. J AIDS 1994;7:410-4.
99. Radka SF, Nakamura S, Sakurada S, et al. Correlation of oncostatin M secretion by human retrovirus-infected cells with potent growth stimulation of cultured spindle cells from AIDS-Kaposi's sarcoma. J Immunol 1993;150: 5195-201.
100. MAPK/ERK-2 in Kaposi's cells: evidence that this pathway is important in Kaposi cell growth. J Clin Invest 1993;92:848-57.
101. Liu J, Modrell B, Aruffo A, et al. Interactions between oncostatin M and the EL-6 signal transducer, gp180. Cytokine 1994;6:272-8.
102. Soldi R, Graziani A, Benelli R, et al. Oncostatin M activates phophatidylinositol-3-kinase in Kaposi's sarcoma cells. Oncogene 1994;9:2253-60.
103. Huang YQ, Li JJ, Kim K-S, et al. HIV-1 infection and modulation of cytokine and growth factor expression in Kaposi's sarcoma-derived cells in vitro. AIDS 1993; 7: 317-22.
104. Ensoli B, Barillari G, Salahuddin SZ, et al. Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients. Nature 1990;345:84-6.
105. Albini A, Fontanini G, Masiello L, et al. Angiogenic potential in vitro by Kaposi's sarcoma cell-free supernatants and HIV-1 tat product: inhibition of KS-like lesions by tissue inhibitor of metalloproteinase-2. AIDS 1994;8: 1237-44.
106. Ensoli B, Gendelman R, Markham P, et al. Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcoma. Nature 1994; 371:674-80.
107. De Paoli P, Caffau C, D'Andrea M, et al. Serum levels of intercellular adhesion molecule 1 in patients with HIV-related Kaposi's sarcoma. J AIDS 1994;7:695-9.
108. Yang J, Hagan MK, Offermann MK. Induction of IL-6 gene expression in Kaposi's sarcoma cells. J Immunol 1994;152:943-55.
109. Yang J, Xu Y, Zhu C, et al. Regulation of adhesion molecule expression in Kaposi's sarcoma cells. J Immunol 1994;152:361-73.
110. Roth WK. TGF β and FGF-like growth factors involved in the pathogenesis of AIDS-associated Kaposi's sarcoma. Res Virol 1993;144:105-9.
111. Huang YQ, Li JJ, Moscatelli D, et al. Expression of int-2 oncogene in Kaposi's sarcoma lesions. J Clin Invest 1993; 91:1191-7.
112. Nicolaides A, Huang YQ, Li JJ, et al. Gene amplification and multiple mutations of the K-ras oncogene in Kaposi's sarcoma Anticancer Res 1994;14:921-6.
113. Naidu YM, Rosen EM, Zitnick R, et al. Role of scatter factor in the pathogenesis of AIDS-related Kaposi sarcoma. Proc Natl Acad Sci U S A 1994;91:5281-5.
114. Hemdier BG, Werner A, Arnstein P, et al. Characterization of a human Kaposi's sarcoma cell line that induces angiogenic tumors in animals. AIDS 1994;8:575-81.
115. Huang YQ, Friedman-Kien AE, Li JJ, et al. Cultured Kaposi's sarcoma cell lines express factor XIIIa, CD 14, and VCAM-1, but not factor VIII or ELAM-1. Arch Dermatol 1993;129:1291-6.
116. Karasek MA. Origin of spindle-shaped cells in Kaposi sarcoma. Lymphology 1994;27:41-4.
117. Zhang Y-M, Bachmann S, Hemmer C. Vascular origin of Kaposi's sarcoma: expression of leukocyte adhesion molecule-1, thrombomodulin, and tissue factor. Am J Pathol 1994;144:51-9.
118. O'Connell KA, Rudmann AA. Cloned spindle and epithelioid cells from murine Kaposi's sarcoma-like tumors are of endothelial origin. J Invest Dermatol 1993;100: 742-5.
119. Gray MH, Trimble CL, Zirn J, et al. Relationship of factor X111a-positive dermal dendrocytes to Kaposi's sarcoma. Arch Pathol Lab Med 1991;115:791-6.
120. Becker J, Schuppan D, Rabanus J-P, et al. Immunoelectron microscopy shows an atypical pattern and a quantitative shift of collagens type I, III, and VI in oral Kaposi's sarcoma of AIDS. Virchows Archiv A Pathol Anat Histopathol 1991;419:237-44.
121. Sauter B, Böcskör B, Födinger D, et al. The histogenesis of Kaposi's sarcoma (KS) cell: immunomorphological comparison with endothelial cells of normal human skin, lymphangioma and hemangiomal [Abstract]. Arch Dermatol Res 1994;286:212.
122. Valcuende-Cavero F, Febrer-Bosch MI, Castells-Rodellas A. Langerhans' cells and lymphocytic infiltrate in AIDS-associated Kaposi's sarcoma: an immunohistochemical study. Acta Derm Venereol (Stockh) 1994; 74:183-7.
123. Goebel F-D, Bogner JR, Liess H, et al. Improvement in diagnosis of visceral Kaposi sarcoma by endoscopic ultrasound (EUS). In: Abstracts: Tenth International Conference on AIDS, International Conference on STD. The global challenge of AIDS: together for the future. Yokohama, Japan. Aug 7-12. 1994. [Abstract PB011] Yokohama, The Conference, 1994:171.
124. Lee VW, Fuller JD, O'Brien MJ, et al. Pulmonary Kaposi sarcoma in patients with AIDS: scintigraphic diagnosis with sequential thallium and gallium scanning. Radiology 1991;180:409-12.
125. Primack BL, Muller NL. High-resolution computed tomography in acute diffuse lung disease in the immunocompromised patient. Radiol Clin North Am 1994;32: 731-44.
126. Del Val Gómez MA, Castro Beiras JM, Gallardo FG, et al. Thallium and gallium scintigraphy in pulmonary Kaposi's sarcoma in an HIV-positive patient. Clin Nucl Med 1994;19:467-8.
127. Gottesman D, Dyrszka H, Albarran J, et al. AIDS-related hepatic Kaposi's sarcoma: massive bleeding following liver biopsy. Am J Gastroenterol 1993;88:762-4.
128. Deziel DJ, Saclarides TJ, Marshall JS, et al. Appendiceal Kaposi's sarcoma: a cause of right lower quadrant pain in the acquired immune deficiency syndrome. Am J Gastroenterol 1991;86:901-3.
129. Ndimbie OK, Kingsley L, Piper M, et al. Longitudinal assessment of basic fibroblast growth factor levels in homosexual men with Kaposi's sarcoma. In: Second National Conference Human Retroviruses and Related Infections sponsored by the American Society for Microbiology in collaboration with National Institutes of Health and Centers for Disease Control, Washington, DC, Jan 29-Feb 2, 1995. [Abstract 163] Washington, DC: American Society for Microbiology, 1995:84.
130. Presant CA, Blayney D, Proffitt RT, et al. Preliminary report: imaging of Kaposi sarcoma and lymphoma in AIDS with indium-111-labelled liposomes. Lancet 1990; 335:1307-9.
131. Bernas M, Enriquez J, Way D, et al. Absence of monoclonal antibody detectable Kaposi sarcoma-specific antigens on lesion-derived cultured cells. Life Sci 1993; 52:663-8.
132. Battocchio S, Chirico E, Marocolo D, et al. Nodal myofibroblatoma in a AIDS patient with disseminated Kaposi's sarcoma. Presented at the 9th International Conference on AIDS, Berlin, June 6-11, 1993 [Abstract. PO-B12-1656] Berlin, Germany, 1993;411.
133. Nielsen H, Nielsen PL. Cutaneous tufted angioma as a differential diagnosis to Kaposi's sarcoma in HIV infection. AIDS 1994;8:707-8.
134. Schwartz RA, Nychay SG, Janniger CK, et al. Bacillary angiomatosis: report of six patients, some with unusual features [Abstract]. J Cutan Pathol 1991;18:388.
135. Schwartz RA, Janniger CK. Bacillary angiomatosis. J AM ACAD DERMATOL 1991;24:802-3, 807-8.
136. Tompkins DC, Steigbigel RT. Rochalimaea's role in cat scratch disease and bacillary angiomatosis. Ann Intern Med 1993;118:388-90.
137. Levell NJ, Bewley AP, Chopra S, et al. Bacillary angiomatosis with cutaneous and oral lesions in an HIV-infected patient from the U.K. Br J Dermatol 1995;132: 113-5.
138. Raoult D, Drancourt M, Carta A, et al. Bartonella. (Rochalimaea) quintana isolation in patient with chronic adenopathy, lymphopenia, and a cat [Letter]. Lancet 1994; 343:97-7.
139. Brenner DJ, O'Connor SP, Winkler HH, et al. Proposals to unify the genera Bartonella and Rochalimaea, with descriptions of Bartonella quintana comb nov Bartonella vinsonii comb nov, Bartonella henselae comb nov, and Bartonella elizabethae comb nov, and to remove the family Bartonellaceae from the order Rickettsiales. Int J Syst Bacteriol 1993;43:777-86.
140. Mooney MA, Janniger CK. Pyogenic granuloma. Cutis 1995;56:133-6.
141. Szybejko-Machaj G, Wasik F, Kaniowska E. Zmiany skórne imituja̧ce melanoma malignum - problem kliniczny. Przegl Dermatol 1994;81:82-5.
142. Schwartz RA. Cutaneous metastatic disease. J AM ACAD DERMATOL 1995;33:161-82.
143. Gascon P, Schwartz RA. Treatment of Kaposi's sarcoma. Dermatol Clin 1994;12:451-6.
144. Klein E, Schwartz RA, Laor Y, et al. Treatment of Kaposi's sarcoma with vinblastine. Cancer 1980;45:427-31.
145. Tappero JW, Berger TG. Caution in the use of local therapies for Kaposi's sarcoma [Letter]. Arch Dermatol 1993; 129:42.
146. Epstein JB. Treatment of oral Kaposi sarcoma with intralesional vinblastine. Cancer 1993;71:1722-5.
147. Boudreaux AA, Smith LL, Cosby CD, et al. Intralesional vinblastine for cutaneous Kaposi's sarcoma associated with acquired immunodeficiency syndrome. J AM ACAD DERMATOL 1993;28:61-5.
148. Lipman MC, Swaden LS, Sabin CA, et al. Kaposi's sarcoma in HIV infection treated with vincristine and bleomycin. AIDS 1993;7:592-3.
149. Konzelman JL, Smith K, Swango P, et al. Vinblastine iontophoresis of Kaposi's sarcoma (KS). In: Eighth International Conference on AIDS/Third STD World Congress, Amsterdam, The Netherlands July 19-24, 1992. Tract B: Poster Clinical Science and Care. [Abstract PoB 3114] Amsterdam: CONGREX Holland BV, 1992.
150. Bogner JR, Kronawitter U, Rolinski B, et al. Liposomal doxorubicin in the treatment of advanced AIDS-related Kaposi sarcoma. J AIDS 1994;7:463-8.
151. Schürmann D, Dormann A, Grünewald T, et al. Successful treatment of AIDS-related pulmonary Kaposi's sarcoma with liposomal daunorubicin. Eur Respir J 1994; 7:824-5.
152. Szelényi H, Armbrecht C, Becker K, et al. Liposomal doxorubicin as a long-term treatment for advanced HIV-associated Kaposi's sarcoma: 30 months of treatment. AIDS 1992;8(suppl 4):S46.
153. Presant CA. Liposomal anthracycline therapy of Kaposi's sarcoma (KS): overview of pilot and multicenter phase 2 trials. AIDS 1994;8(suppl 4):S11.
154. Remick SC, Reddy M, Herman D, et al. Continuous infusion bleomycin in AIDS-related Kaposi's sarcoma. J Clin Oncol 1994;12:1130-6.
155. Corbeil J, Richman DD, Wrasidlo W, et al. Antiproliferative effects of enediynes on AIDS-derived Kaposi's sarcoma cells. Cancer Res 1994;54:4270-3.
156. Klein E, Schwartz RA, Case RW, et al. Accessible tumors. In: LoBuglio AF, ed. Clinical immunotherapy. New York: Marcel Dekker, 1980:31-71.
157. O'Connell KA. Resolution of Kaposi's sarcoma [Letter]. Lancet 1994;343:741.
158. LeMaistre CF, Craig F, Smith J, et al. Phase I/II evaluation of an IL-2 receptor targeted fusion toxin, DAB486IL-2, for treatment of AIDS-associated Kaposi's sarcoma. In: Abstracts, Seventh International Conference on AIDS, Florence Italy, June 16-21, 1991; Istituto Superiore di Sanita, Rome, The Conference, 1991:TU.B.85;79.
159. Micheletti GA Jr, Adams A, Garland J, et al. Topical treatment of cutaneous Kaposi's angiosarcoma with DNCB. In: Seventh International Conference on AIDS/ 3rd STD World Congress, Amsterdam, The Netherlands July 19-24, 1992. [Abstracts, Indexes] Tract B: Poster Clinical Science and Care. (Publication No. 7361.) Amsterdam: CONGREX Holland BV, 1992.
160. Pluda JM. Inhibition of angiogenesis as a potential therapeutic strategy for the treatment of AIDS-associated Kaposi's sarcoma (KS) [Abstract]. AIDS 1994;8(suppl 4):S11.
161. Nakamura S, Sakurada S, Salahunddin SZ, et al. Inhibition of HIV development of Kaposi's sarcoma-related lesions by a bacterial wall complex. Science 1992;255:1437-40.
162. Witte MH, Borgs P, Way DL, et al. Kaposi's sarcoma, vascular permeability, and scientific integrity. JAMA 1994;271:1769-71.
163. Pluda JM, Shay LE, Poli A, et al. Administration of pentosan polysulfate to patients with human immunodeficiency virus-associated Kaposi's sarcoma. J Natl Cancer Inst 1993;85:1585-92.
164. Petit RG, Miles S, Magpantay L, et al. Vesnarinone inhibits AIDS-KS cells in culture. In: Abstracts: Tenth International Conference on AIDS, International Conference on STD. The global challenge of AIDS: together for the future. Yokohama, Japan, Aug 7-12, 1994. [Abstract PBO104) Yokohama, The Conference, 1994:169.
165. Krown SE. Kaposi's sarcoma: biologic therapy with interferons and retinoids [Abstract]. AIDS 1994;8(suppl 4):S12.
166. Tur E, Brenner S, Michalevicz R. Low dose recombinant Interferon alfa treatment for classic Kaposi's sarcoma. Arch Dermatol 1993;129:1297-300.
167. Podzamczer D, Bolao F, Clotet B, et al. Low-dose interferon alpha combined with zidovudine in patients with AIDS-associated Kaposi's sarcoma. J Intern Med 1993; 233:247-53.
168. Porta F, Bongiorno M, Locatelli F, et al. Kaposi's sarcoma in a child after autologous bone marrow transplantation for non-Hodkin's lymphoma. Cancer 1991;68:1361-4.
169. Mitsuyasa RT, Miles SA. The role of cytokines and cytokine inhibitors in AIDS-related Kaposi's sarcoma [Abstract]. AIDS 1994;8(suppl 4):S11.
170. Corbeil J, Rapaport E, Richman DD, et al. Antiproliferative effect of retinoid compounds on Kaposi's sarcoma cells. J Clin Invest 1994;93:1981-6.
171. Corbeil J, Rapaport E, Richman D, et al. Inhibition and killing of Kaposi's sarcoma cells by retinoids. In: Second National Conference Human Retroviruses and Related Infections, sponsored by the American Society for Microbiology in collaboration with National Institutes of Health and the Centers for Disease Control, Washington, DC, Jan 29-Feb 2, 1995. (Abstract 135) Washington, DC: American Society for Microbiology, 1995:79.
172. von Roenn I, von Gunten C, Mullane M, et al. All trans-retinoic acid (TRA) in the treatment of AIDS-related Kaposi's sarcoma. In: Ninth International Conference on AIDS. Berlin, June 6-11, 1993. Abstract Book. Berlin, Germany: Institute for Clinical and Experimental Virology of the Free University of Berlin, 1993:PoB12-1571;397.
173. Brockmeyer NH, Hengge UR, Jura S, et al. Fumagillol and isotretinoin inhibit in vitro Kaposi's sarcoma cell growth [Abstract]. J Invest Dermatol 1993;100:558.
174. Klimas N, Fletcher M, Walling J, et al. Response of Kaposi's sarcoma (KS) to autologous CD8 cells expanded and activated ex vivo and re-infused with rIL-2. In: Ninth International Conference on AIDS in affiliation with the Fourth STD World Congress. Berlin, June 6-11, 1993. Abstract Book; WS-B15-2. Berlin, Germany: Institute for Clinical and Experimental Virology of the Free University of Berlin, 1993.
175. Alonso K, Pontiggia P, Sabato A, et al. Systemic hyperthermia in the treatment of HIV-related disseminated Kaposi's sarcoma: long-term follow-up of patients treated with low-flow extracorporeal perfusion hyperthermia. Am J Clin Oncol 1994;17:353-9.
176. Gill PS, Rarick M, McCutohan JA, et al. Systemic treatment of AIDS-related Kaposi's sarcoma: results of a randomized trial. Am J Med 1991;90:427-33.
177. Shepherd FA, Burkes RL, Paul KE, et al. A phase II study of 4′-epirubicin in the treatment of poor-risk Kaposi's sarcoma and AIDS. AIDS 1991;5:305-9.
178. Sprinz E, Sander E, Kalakun L, et al. Epipodophyllotoxins in AIDS-related Kaposi's sarcoma: the SOAD experience. In: Ninth International Conference on AIDS. June 6-11, 1993. Abstract Book. (Abstract PO-B12-1563;396) Berlin, Germany: Institute for Clinical and Experimental Virology of the Free University of Berlin, 1993.
179. Tappero JW, Grekin RC, Zanelli GA, et al. Pulsed-dye laser therapy for cutaneous Kaposi's sarcoma associated with acquired immunodeficiency syndrome. J AM ACAD DERMATOL 1992;27:526-30.
180. Langtry JAA, Bottomley DM, Phillips RH, et al. The infra-red coagulator in the treatment of AIDS-related Kaposi's sarcoma and a comparison with radiotherapy. Clin Exp Dermatol 1994;19:23-5.
181. Stelzer KJ, Griffin TW. A randomized prospective trial of radiation therapy for AIDS-associated Kaposi's sarcoma, Int J Radiat Oncol Biol Phys 1993;27:1057-61.
182. Kaliebe T, Schmitz T, Schröder U, et al. Cryotherapy of AIDS-related Kaposi's sarcoma. In: Ninth International Conference on AIDS. Berlin, June 6-11, 1993. Abstract Book. (Abstract PO-B12-1601;103) Berlin, Germany: Institute for Clinical and experimental Virology of the Free University of Berlin, 1993:103.
183. Hebeda K, Bakker BJM, Huizing MT, et al. Photodynamic therapy (PDT) in AIDS-related cutaneous Kaposi's sarcoma. In: Ninth International Conference on AIDS. Berlin, June 6-11, 1993. Abstract Book. (PO-B12-1599) Berlin, Germany: Institute for Clinical and Experimental Virology of the Free University of Berlin, 1993:103.
184. Stein ME, Lakier R, Kuten A, et al. Radiation therapy in endemic (African) Kaposi's sarcoma. Int J Radiat Oncol Biol Phys 1993;27:1181-4.
185. Stein ME, Lakier R, Spencer D, et al. Radiation therapy for non-AIDS associated (classic and endemic African) and epidemic Kaposi's sarcoma. Int J Radiat Oncol Biol Phys 1994;28:613-9.
186. Ruszczak Z, Stadler R, Schwartz RA. Kaposi's sarcoma limited to penis treated with cobalt-60 radiotherapy. J Med (In press).
187. Doyle M, Johnstone PAS, Watkins EB. Role of radiation therapy in management of pulmonary Kaposi's sarcoma. South Med J 1993;86:285-8.
188. ™) as therapy for HIV-associated Kaposi's sarcoma (KS). In: Second National Conference Human Retroviruses and Related Infections, sponsored by the American Society for Microbiology in collaboration with National Institutes of Health and the Centers for Disease Control, Washington, DC, Jan 29-Feb 2, 1995. (Abstract 134) Washington, DC: American Society for Microbiology, 1995:79.